Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors
Clinical trial NCT02744287 · TERMINATED
Trial details
- NCT number
- NCT02744287
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-30
- Primary completion
- 2023-03-14
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.